Elevated Circulating LINC-P21 Serves as a Diagnostic Biomarker of Type 2 Diabetes Mellitus and Regulates Pancreatic β-cell Function by Sponging miR-766-3p to Upregulate NR3C2.

MLA

Cao, Zhibin, et al. “Elevated Circulating LINC-P21 Serves as a Diagnostic Biomarker of Type 2 Diabetes Mellitus and Regulates Pancreatic β-Cell Function by Sponging MiR-766-3p to Upregulate NR3C2.” Experimental & Clinical Endocrinology & Diabetes, vol. 130, no. 3, Mar. 2022, pp. 156–64. EBSCOhost, https://doi.org/10.1055/a-1247-4978.

APA

Cao, Z., Yao, F., Lang, Y., & Feng, X. (2022). Elevated Circulating LINC-P21 Serves as a Diagnostic Biomarker of Type 2 Diabetes Mellitus and Regulates Pancreatic β-cell Function by Sponging miR-766-3p to Upregulate NR3C2. Experimental & Clinical Endocrinology & Diabetes, 130(3), 156–164. https://doi.org/10.1055/a-1247-4978

Chicago

Cao, Zhibin, Fuwang Yao, Yuqin Lang, and Xueqiang Feng. 2022. “Elevated Circulating LINC-P21 Serves as a Diagnostic Biomarker of Type 2 Diabetes Mellitus and Regulates Pancreatic β-Cell Function by Sponging MiR-766-3p to Upregulate NR3C2.” Experimental & Clinical Endocrinology & Diabetes 130 (3): 156–64. doi:10.1055/a-1247-4978.